These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29298646)

  • 1. Tacrolimus - Pharmacokinetic Considerations for Clinicians.
    Schutte-Nutgen K; Tholking G; Suwelack B; Reuter S
    Curr Drug Metab; 2018; 19(4):342-350. PubMed ID: 29298646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended-Release Once-Daily Tacrolimus Tablets.
    Philosophe B; Leca N; West-Thielke PM; Horwedel T; Culkin-Gemmell C; Kistler K; Stevens DR
    J Clin Pharmacol; 2018 Jul; 58(7):891-896. PubMed ID: 29462506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
    Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
    Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the pharmacokinetics of extended-release tacrolimus (LCP-TAC) to immediate-release formulations in kidney transplant patients.
    Tan T; Bunnapradist S
    Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1175-1186. PubMed ID: 34459696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion to tacrolimus extended-release formulation: short-term clinical results.
    Gallego-Valcarce E; Ortega-Cerrato A; Llamas-Fuentes F; Martinez-Fernandez G; Perez-Martinez J; Gomez-Roldan C
    Transplant Proc; 2009; 41(6):2326-7. PubMed ID: 19715909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients.
    Tanzi MG; Undre N; Keirns J; Fitzsimmons WE; Brown M; First MR
    Clin Transplant; 2016 Aug; 30(8):901-11. PubMed ID: 27220013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of a once-daily formulation of tacrolimus in patients with renal transplantation.
    Imanishi Y; Matsui K; Ishida K; Ito S; Matsuura K; Deguchi T; Itoh Y
    Arzneimittelforschung; 2011; 61(3):191-6. PubMed ID: 21528645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients.
    Stifft F; Undre N; van Hooff JP; Christiaans MH
    Ther Drug Monit; 2016 Aug; 38(4):456-62. PubMed ID: 27128604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.
    Shihab F; Christians U; Smith L; Wellen JR; Kaplan B
    Transpl Immunol; 2014 Jun; 31(1):22-32. PubMed ID: 24861504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
    Niioka T; Satoh S; Kagaya H; Numakura K; Inoue T; Saito M; Narita S; Tsuchiya N; Habuchi T; Miura M
    Transplantation; 2012 Nov; 94(10):1013-9. PubMed ID: 23073468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations.
    Coilly A; Calmus Y; Chermak F; Dumortier J; Duvoux C; Guillaud O; Houssel-Debry P; Neau-Cransac M; Stocco J
    Liver Transpl; 2015 Oct; 21(10):1312-21. PubMed ID: 26264233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy.
    Min SI; Ha J; Kang HG; Ahn S; Park T; Park DD; Kim SM; Hong HJ; Min SK; Ha IS; Kim SJ
    Am J Transplant; 2013 Aug; 13(8):2191-7. PubMed ID: 23734831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N
    Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus-why pharmacokinetics matter in the clinic.
    Henkel L; Jehn U; Thölking G; Reuter S
    Front Transplant; 2023; 2():1160752. PubMed ID: 38993881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients.
    Heffron TG; Pescovitz MD; Florman S; Kalayoglu M; Emre S; Smallwood G; Wisemandle K; Anania C; Dhadda S; Sawamoto T; Keirns J; Fitzsimmons W; First MR
    Am J Transplant; 2007 Jun; 7(6):1609-15. PubMed ID: 17511684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.